Correction to: Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
- PMID: 32319075
- DOI: 10.1007/s40265-020-01315-x
Correction to: Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Abstract
The article Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder, written by James E. Frampton, was originally published electronically in SpringerLink on 7 April 2020 without Open Access. After publication Alexion Pharmaceuticals, Inc., requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Alexion Pharmaceuticals, Inc.
Erratum for
-
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder.Drugs. 2020 May;80(7):719-727. doi: 10.1007/s40265-020-01297-w. Drugs. 2020. PMID: 32266705 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous